Clinical Trial Update: Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating pegmolesatide for anemia in patients undergoing long-term dialysis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Pegmolesatide

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Dialysis; Complications, Chronic Kidney Disease 5D | Phase 4 | Status: RECRUITING